CEL-SCI Corp Files 8-K on Security Holder Vote Matters

Ticker: CVM · Form: 8-K · Filed: May 19, 2025 · CIK: 725363

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting

TL;DR

CEL-SCI Corp is having a shareholder vote meeting.

AI Summary

CEL-SCI Corporation filed an 8-K on May 19, 2025, reporting a submission of matters to a vote of security holders. The company, incorporated in Colorado, is involved in the biological products sector and is headquartered in Vienna, VA.

Why It Matters

This filing indicates that CEL-SCI Corporation is engaging its security holders on important corporate decisions, which could impact the company's future direction and shareholder value.

Risk Assessment

Risk Level: low — The filing is a routine procedural report regarding a vote of security holders and does not disclose any immediate financial distress or significant operational changes.

Key Numbers

Key Players & Entities

FAQ

What specific matters are being submitted for a vote of security holders?

The filing does not specify the exact matters to be voted on, only that matters are being submitted for a vote of security holders.

When was CEL-SCI CORPORATION incorporated?

CEL-SCI CORPORATION was incorporated in Colorado, as stated in the filing.

What is the company's primary business sector?

The company is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.

Has the company's name changed previously?

Yes, the company was formerly known as INTERLEUKIN 2 INC, with a name change date of March 17, 1988.

Where are CEL-SCI CORPORATION's principal executive offices located?

The principal executive offices are located at 8229 Boone Blvd., #802 Vienna, VA 22182.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding CEL SCI CORP (CVM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing